CDIO
Cardio Diagnostics Holdings, Inc.Company Information
- Company Name
- Cardio Diagnostics Holdings, Inc.
- CIK
- CIK0001870144
- Category
- <br>Emerging growth company
- Ticker: Exchange
- CDIO: Nasdaq, CDIOW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2835
- SIC Description
- In Vitro & In Vivo Diagnostic Substances
- Ticker
- CDIO
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-09-06
- Last sale
- —
- Shares purchased (TTM)
- 378,900
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 193,029
- Shares outstanding
- 2,959,469
- Ownership
- 6.52%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- 3.35%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 6 | 7 | 5 | 6 | 8 | 10 | 8 | 2 | 1 | 2 | 1 | 4 | ||||||
| Accounts Receivable Net Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Assets Current | 6 | 8 | 6 | 7 | 9 | 11 | 9 | 3 | 2 | 3 | 3 | 5 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deposits Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Intangible Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Assets | 8 | 10 | 8 | 9 | 10 | 12 | 11 | 4 | 4 | 4 | 4 | 6 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Notes Payable Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Derivative Liabilities Current | - | - | - | - | - | - | - | - | - | - | - | 1 | ||||||
| Liabilities Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 3 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Liabilities | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 40 | 40 | 36 | 36 | 36 | 36 | 32 | 25 | 23 | 22 | 17 | 15 | ||||||
| Retained Earnings Accumulated Deficit | -33 | -31 | -29 | -28 | -26 | -24 | -23 | -21 | -20 | -19 | -14 | -13 | ||||||
| Stockholders Equity | 7 | 9 | 7 | 8 | 10 | 11 | 10 | 4 | 3 | 3 | 3 | 2 | ||||||
| Liabilities And Stockholders Equity | 8 | 10 | 8 | 9 | 10 | 12 | 11 | 4 | 4 | 4 | 4 | 6 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | - | 300 | 300 | ||||||
| Common Stock Shares Issued | 3 | 3 | - | 2 | 2 | 2 | 2 | 1 | 1 | - | 1 | 0 | ||||||
| Shares Outstanding | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | - | 1 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCardio Diagnostics Holdings, Inc. (CDIO) — SEC Financial Statements & Analysis
Cardio Diagnostics Holdings, Inc. (CDIO) is a in vitro & in vivo diagnostic substances company, incorporated in DE. Cardio Diagnostics Holdings, Inc. trades on Nasdaq as: CDIO, CDIOW. Cardio Diagnostics Holdings, Inc. (CDIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, Cardio Diagnostics Holdings, Inc. carries a market cap of $6.48M, a P/E ratio of -1.00x, a P/B ratio of 0.87x, a P/S ratio of 448.53x, an enterprise value of $894.54K, and an EV/EBITDA multiple of -0.14x. On profitability, it posts a gross margin of 185.11%, an operating margin of -44690.68%, a net margin of -44771.83%, a Return on Equity (ROE) of -75.44%, a Return on Assets (ROA) of -70.62%, and a Return on Invested Capital (ROIC) of -358.92%. Per share, it reports EPS of $-2.19, diluted EPS of $-2.19, free cash flow per share of $-2.01, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -25.92% year-over-year, net income growth of 3.51% year-over-year, and EPS growth of -39.18% year-over-year. On the balance sheet, it maintains a current ratio of 17.15x, a quick ratio of 15.56x, working capital of $5.80M, a debt-to-equity ratio of 0.07x, a debt ratio of 0.06, an interest coverage ratio of -525.07x, free cash flow of $-5.95M (TTM), and net debt of $-5.59M. Figures sourced from SEC EDGAR.
- Market Cap
- $6.48M
- P/E TTM
- -1.00x
- EPS TTM
- $-2.19
- P/B TTM
- 0.87x
- ROE TTM
- -75.44%
- ROA TTM
- -70.62%
- Debt To Equity
- 0.07x
- Free Cash Flow TTM
- $-5.95M
- Net Revenue TTM Growth 1Y
- -25.92%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Cardio Diagnostics Holdings, Inc. in?
Cardio Diagnostics Holdings, Inc. (CDIO) operates in the In Vitro & In Vivo Diagnostic Substances industry.
What exchange does CDIO trade on?
Cardio Diagnostics Holdings, Inc. (CDIO) trades on the Nasdaq.
Where is Cardio Diagnostics Holdings, Inc. incorporated?
Cardio Diagnostics Holdings, Inc. is incorporated in DE.
When was Cardio Diagnostics Holdings, Inc. (CDIO)'s most recent SEC filing?
Cardio Diagnostics Holdings, Inc. (CDIO)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is CDIO's market cap?
Cardio Diagnostics Holdings, Inc. (CDIO) has a market capitalization of $6.48M as of 2026-06-30.
What is CDIO's EPS (earnings per share)?
Cardio Diagnostics Holdings, Inc. (CDIO)'s trailing twelve month EPS is $-2.19 as of 2026-06-30.
What is CDIO's ROE (return on equity)?
Cardio Diagnostics Holdings, Inc. (CDIO)'s trailing twelve month Return on Equity (ROE) is -75.44% as of 2026-06-30.
What is CDIO's ROA (return on assets)?
Cardio Diagnostics Holdings, Inc. (CDIO)'s trailing twelve month Return on Assets (ROA) is -70.62% as of 2026-06-30.
What is CDIO's ROIC (return on invested capital)?
Cardio Diagnostics Holdings, Inc. (CDIO)'s trailing twelve month Return on Invested Capital (ROIC) is -358.92% as of 2026-06-30.
What is CDIO's EV/EBITDA?
Cardio Diagnostics Holdings, Inc. (CDIO)'s trailing twelve month EV/EBITDA is -0.14x as of 2026-06-30.